Annual Operating Expenses
$79.13 M
-$10.02 M-11.24%
December 31, 2023
Summary
- As of March 8, 2025, XLO annual total operating expenses is $79.13 million, with the most recent change of -$10.02 million (-11.24%) on December 31, 2023.
- During the last 3 years, XLO annual operating expenses has risen by +$24.57 million (+45.03%).
- XLO annual operating expenses is now -11.24% below its all-time high of $89.15 million, reached on December 31, 2022.
Performance
XLO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$17.07 M
+$35.00 K+0.21%
September 30, 2024
Summary
- As of March 8, 2025, XLO quarterly total operating expenses is $17.07 million, with the most recent change of +$35.00 thousand (+0.21%) on September 30, 2024.
- Over the past year, XLO quarterly operating expenses has dropped by -$1.06 million (-5.87%).
- XLO quarterly operating expenses is now -30.49% below its all-time high of $24.55 million, reached on June 30, 2022.
Performance
XLO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
XLO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.2% | -5.9% |
| 3 y3 years | +45.0% | -5.9% |
| 5 y5 years | - | -5.9% |
XLO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.2% | +5.5% | -30.5% | +3.2% |
| 5 y | 5-year | -11.2% | +315.9% | -30.5% | +16.7% |
| alltime | all time | -11.2% | +315.9% | -30.5% | +16.7% |
Xilio Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.07 M(+0.2%) |
| Jun 2024 | - | $17.03 M(+3.0%) |
| Mar 2024 | - | $16.54 M(-8.8%) |
| Dec 2023 | $79.13 M(-11.2%) | $18.13 M(+4.4%) |
| Sep 2023 | - | $17.36 M(-13.7%) |
| Jun 2023 | - | $20.12 M(-14.5%) |
| Mar 2023 | - | $23.53 M(+1.5%) |
| Dec 2022 | $89.15 M | $23.17 M(+14.7%) |
| Sep 2022 | - | $20.21 M(-17.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $24.55 M(+15.7%) |
| Mar 2022 | - | $21.22 M(+8.5%) |
| Dec 2021 | $75.04 M(+37.5%) | $19.56 M(+22.5%) |
| Sep 2021 | - | $15.96 M(-30.6%) |
| Jun 2021 | - | $23.01 M(+39.3%) |
| Mar 2021 | - | $16.52 M(-19.8%) |
| Dec 2020 | $54.56 M(+186.8%) | $20.59 M(+40.8%) |
| Sep 2020 | - | $14.62 M |
| Dec 2019 | $19.03 M | - |
FAQ
- What is Xilio Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Xilio Therapeutics?
- What is Xilio Therapeutics annual operating expenses year-on-year change?
- What is Xilio Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly operating expenses year-on-year change?
What is Xilio Therapeutics annual total operating expenses?
The current annual operating expenses of XLO is $79.13 M
What is the all time high annual operating expenses for Xilio Therapeutics?
Xilio Therapeutics all-time high annual total operating expenses is $89.15 M
What is Xilio Therapeutics annual operating expenses year-on-year change?
Over the past year, XLO annual total operating expenses has changed by -$10.02 M (-11.24%)
What is Xilio Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of XLO is $17.07 M
What is the all time high quarterly operating expenses for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly total operating expenses is $24.55 M
What is Xilio Therapeutics quarterly operating expenses year-on-year change?
Over the past year, XLO quarterly total operating expenses has changed by -$1.06 M (-5.87%)